Infographic. Number of sterile syringes distributed per person who injects drugs and proportion of high-risk opioid users in opioid agonist treatment (OAT)

This graphic is part of the Elimination barometer on viral hepatitis among people who inject drugs in Europe (prevention component).

Figure. Number of sterile syringes distributed per person who injects drugs and proportion of high-risk opioid users in opioid agonist treatment (OAT), by country, latest available data

Source data

(Syringes per person who injects drugs) (Proportion in OST)
Country	People who inject drugs, year of estimate	Number people who inject drugs	High-risk opioid use, year of estimate	Number high-risk opioid users	Total number of syringes distributed	Total number of OST clients	Proportion in OST	Syringes per person who injects drugs
Croatia	2015	6344	2015	8874	376537	5202	0.59	59
Cyprus	2020	710	2020	974	7920	208	0.21	11
Czechia	2020	42200	2020	11100	8892977	5000	0.45	211
Finland	2017	25000	2017	26200	6595051	4729	0.18	264
France	2019	129703	2019	202485	12572530	177100	0.87	97
Greece	2020	2488	2020	12351	386745	9211	0.75	155
Latvia	2016	7715	2017	7100	1118439	721	0.1	145
Lithuania	2016	8868	2016	7503	245592	1044	0.14	28
Luxembourg	2019	822	2019	1427	394690	1176	0.82	480
Norway	2019	8476	2013	9015	3400000	8099	0.9	401
Portugal	2015	13162	2018	28287	1155728	17614	0.62	88
Spain	2019	9158	2019	63660	1821923	58540	0.92	199
Belgium	2019	7018	2019		1243152			177

Originally published in:

Elimination barometer on viral hepatitis among people who inject drugs in Europe

PDF version

Main subject

drug-related infectious diseases

Keywords

#ResponsesGuide

health and social responses

injecting drug use

needle and syringe provision

OAT (opioid agonist treatment)

treatment monitoring

Target audience

Media type:

Published date:

July 2021

CC-BY-4.0

Download (0.2 MB)

Loading